title: Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up.
abstract: BACKGROUND
  Multi-drug resistant tuberculosis has emerged as a significant problem with the resurfacing of tuberculosis and thus the need to use the second line drugs with the resultant increased incidence of adverse effects. We discuss the effect of second line aminoglycoside anti-tubercular drugs on the hearing status of MDR-TB patients.
  
  
  METHODS
  Sixty four patients were put on second line aminoglycoside anti-TB drugs. These were divided into three groups: group I, 34 patients using amikacin, group II, 26 patients using kanamycin and group III, 4 patients using capreomycin.
  
  
  RESULTS
  Of these, 18.75% of the patients developed sensorineural hearing loss involving higher frequencies while 6.25% had involvement of speech frequencies also. All patients were seen again approximately one year after aminoglycoside discontinuation and all hearing losses were permanent with no threshold improvement.
  
  
  CONCLUSIONS
  Aminoglycosides used in MDR-TB patients may result in irreversible hearing loss involving higher frequencies and can become a hearing handicap as speech frequencies are also involved in some of the patients thus underlining the need for regular audiologic evaluation in patients of MDR-TB during the treatment.
authors.affiliation: Department of Otolaryngology, Dr, Rajinder Prasad Govt, Medical College, Tanda, Kangra, Himachal Pradesh, India. duggalprahlad@yahoo.co.in
authors.forename: Prahlad
authors.initials: P
authors.lastname: Duggal
authors.forename: Malay
authors.initials: M
authors.lastname: Sarkar